Abstract
Background
Surgical-site infections after reduction mammaplasty are associated with poor cosmetic results. This study investigated the postoperative antiinflammatory influence of hydroxyethyl starch and its effect on surgical-site infections after breast reduction.
Methods
In this prospective case–control study, 334 patients undergoing reduction mammaplasty were prospectively assigned in a 2:1 ratio to receive either 2 × 250 ml of hydroxyethyl starch 6 % or saline solution 0.9 % for 3 days postoperatively. Patient follow-up evaluation was at least 1 month. Using uni- and multivariate analyses, this study aimed to identify risk factors for surgical-site infections and nipple necrosis.
Results
Surgical-site infections occurred in 6.6 % of the hydroxyethyl starch group and in 3.6 % of the control group (p = 0.704). Hydroxyethyl starch had no effect of reducing surgical-site infections [p = 0.212; odds ratio (OR), 0.317; confidence interval (CI), 0.052–1.925]. According to univariate analyses, hydroxyethyl starch reduced the occurrence of postoperative fever (p = 0.085; OR 0.608; CI 0.345–1.072), and fever was associated with increased infection rates (p = 0.033; OR 2.335; CI 1.071–5.089). Additional risk factors for postoperative infections were diabetes (p = 0.051; OR 4.051; CI 0.997–16.463) and obesity (normal weight vs grade ≥2: p = 0.003; OR 7.612; CI 2.031–28.529). Multivariate analysis showed no independent predictors for surgical-site infections. Nipple necrosis were equally observed in the two groups (p = 0.458; OR 1.643; CI 0.443–6.097).
Conclusion
The antiinflammatory approach of hydroxyethyl starch did not lead to a decrease in infections or nipple necrosis. No difference in surgical-site infections was observed between aesthetic and oncologic procedures.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
Cunningham M, Bunn F, Handscomb K (2006) Prophylactic antibiotics to prevent surgical-site infection after breast cancer surgery. Cochrane Database Syst Rev 19(2):CD005360. doi:10.1002/14651858.CD005360.pub2
Throckmorton AD, Boughey JC, Boostrom SY, Holifield AC, Stobbs MM, Hoskin T, Baddour LM, Degnim AC (2009) Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol 16:2464–2469. doi:10.1245/s10434-009-0542-1
Throckmorton AD, Hoskin T, Boostrom SY, Boughey JC, Holifield AC, Stobbs MM, Baddour LM, Degnim AC (2009) Complications associated with postoperative antibiotic prophylaxis after breast surgery. Am J Surg 198:553–556. doi:10.1016/j.amjsurg.2009.06.003
Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ (2008) Hospital-associated costs due to surgical-site infection after breast surgery. Arch Surg 143:53–60. doi:10.1001/archsurg.2007.11 (Discussion 61)
Brem H, Tomic-Canic M (2007) Cellular and molecular basis of wound healing in diabetes. J Clin Invest 117:1219–1222. doi:10.1172/JCI32169
Gabbita SP, Robinson KA, Stewart CA, Floyd RA, Hensley K (2000) Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys 376:1–13. doi:10.1006/abbi.1999.1685
Andrades P, Fix RJ, Danilla S, Howell RE III, Campbell WJ, De la Torre J, Vasconez LO (2008) Ischemic complications in pedicle, free, and muscle-sparing transverse rectus abdominis myocutaneous flaps for breast reconstruction. Ann Plast Surg 60:562–567. doi:10.1097/SAP.0b013e31816fc372
Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44:681–699
Yokoe DS, Noskin GA, Cunnigham SM, Zuccotti G, Plaskett T, Fraser VJ, Olsen MA, Tokars JI, Solomon S, Perl TM, Cosgrove SE, Tilson RS, Greenbaum M, Hooper DC, Sands KE, Tully J, Herwaldt L, Diekema DJ, Wong ES, Climo M, Platt R (2004) Enhanced identification of postoperative infections among inpatients. Emerg Infect Dis 10:1924–1930
Barone JE (2009) Fever: fact and fiction. J Trauma 67:406–409. doi:10.1097/TA.0b013e3181a5f335
Sund-Levander M, Forsberg C, Wahren LK (2002) Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review. Scand J Caring Sci 16:122–128. doi:069
Centers for Disease Control and Prevention: Defining Overweight and Obesity. Retrieved 16 Feb 2012 at http://www.cdc.gov/obesity/defining.html
Bain BJ, Bates I (2001) Basic haematological techniques. In: Lewis SM, Bain BJ, Bates I (eds) Practical haematology, 9th edn. Churchill Livingstone, Edinburgh, pp 19–46
World Health Organisation (1968): Nutritional Anemia: Report of a WHO Scientific Group. World Health Organisation: Geneva. Retrieved 02 Dec 2012 at http://whqlibdoc.who.int/trs/WHO_TRS_405.pdf
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250–278. doi:10.1086/501620 (quiz 279–280)
Esposito S, Leone S, Noviello S, Ianniello F, Marvaso A, Cuniato V, Bellitti F (2006) Antibiotic prophylaxis in hernia repair and breast surgery: a prospective randomized study comparing piperacillin/tazobactam versus placebo. J Chemother 18:278–284
Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT (2000) Antibiotic prophylaxis for postoperative wound infection in clean elective breast surgery. Eur J Surg Oncol 26:363–366. doi:10.1053/ejso.1999.0899
D’Amico DF, Parimbelli P, Ruffolo C (2001) Antibiotic prophylaxis in clean surgery: Breast surgery and hernia repair. J Chemother 13(Spec no. 1):108–111
Corion LU, Smeulders MJ, van Zuijlen PP, van der Horst CM (2009) Draining after breast reduction: a randomised controlled inter-patient study. J Plast Reconstr Aesthet Surg 62:865–868. doi:10.1016/j.bjps.2008.01.009
Anzarut A, Edwards DC, Calder K, Guenther CR, Tsuyuki R (2008) Superior pedicle breast reduction techniques increase the risk of postoperative drainage. Ann Plast Surg 60:367–371. doi:10.1097/SAP.0b013e31812f7ba7
Collis N, McGuiness CM, Batchelor AG (2005) Drainage in breast reduction surgery: a prospective randomised intra-patient trail. Br J Plast Surg 58:286–289. doi:10.1016/j.bjps.2004.11.018
Kop EC, Spauwen PH, Kouwenberg PP, Heymans FJ, van Beem HB (2009) Influence of controlled hypotension versus normotension on amount of blood loss during breast reduction. J Plast Reconstr Aesthet Surg 62:200–205. doi:10.1016/j.bjps.2007.10.033
Olsen MA, Lefta M, Dietz JR, Brandt KE, Aft R, Matthews R, Mayfield J, Fraser VJ (2008) Risk factors for surgical site infection after major breast operation. J Am Coll Surg 207:326–335. doi:10.1016/j.jamcollsurg.2008.04.021
Kompatscher P, von Planta A, Spicher I, Seifert B, Vetter S, Minder J, Beer GM (2003) Comparison of the incidence and predicted risk of early surgical-site infections after breast reduction. Aesthetic Plast Surg 27:308–314. doi:10.1007/s00266-003-3010-5
Hunter-Smith DJ, Smoll NR, Marne B, Maung H, Findlay MW (2012) Comparing breast-reduction techniques: time-to-event analysis and recommendations. Aesthetic Plast Surg. doi:10.1007/s00266-011-9860-3
Gulcelik MA, Dogan L, Camlibel M, Karaman N, Kuru B, Alagol H, Ozaslan C (2011) Early complications of a reduction mammoplasty technique in the treatment of macromastia with or without breast cancer. Clin Breast Cancer 11:395–399. doi:10.1016/j.clbc.2011.08.001
Shermak MA, Chang D, Buretta K, Mithani S, Mallalieu J, Manahan M (2011) Increasing age impairs outcomes in breast reduction surgery. Plast Reconstr Surg 128:1182–1187. doi:10.1097/PRS.0b013e318230c467
Munhoz AM, Aldrighi CM, Montag E, Arruda E, Brasil JA, Filassi JR, Aldrighi JM, Gemperli R, Ferreira MC (2011) Outcome analysis of immediate and delayed conservative breast surgery reconstruction with mastopexy and reduction mammaplasty techniques. Ann Plast Surg 67:220–225. doi:10.1097/SAP.0b013e3181f77bba
Stevens WG, Gear AJ, Stoker DA, Hirsch EM, Cohen R, Spring M, Vath SD, Schantz SA, Heck RT (2008) Outpatient reduction mammaplasty: an eleven-year experience. Aesthet Surg J 28:171–179. doi:10.1016/j.asj.2008.01.001
Chun YS, Schwartz MA, Gu X, Lipsitz SR, Carty MJ (2012) Body mass index as a predictor of postoperative complications in reduction mammaplasty. Plast Reconstr Surg 129:228e–233e. doi:10.1097/PRS.0b013e31823ae949
Zoumaras J, Lawrence J (2008) Inverted-T versus vertical scar breast reduction: one surgeon’s 5-year experience with consecutive patients. Aesthet Surg J 28:521–526. doi:10.1016/j.asj.2008.07.003 (Discussion 526–527)
James A, Verheyden C (2011) A retrospective study comparing patient outcomes of wise pattern-inferior pedicle and vertical pattern-medial pedicle reduction mammoplasty. Ann Plast Surg 67:481–483. doi:10.1097/SAP.0b013e3181fc0523
**e J, Lv R, Yu L, Huang W (2010) Hydroxyethyl starch 130/0.4 exerts its antiinflammatory effect in endotoxemic rats by inhibiting the TLR4/NF-kappaB signaling pathway. Ann Clin Lab Sci 40:240–246
Dubin A, Pozo MO, Casabella CA, Murias G, Palizas F Jr, Moseinco MC, Kanoore Edul VS, Palizas F, Estenssoro E, Ince C (2010) Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 25:e651–e658, 659. doi:10.1016/j.jcrc.2010.04.007
**e J, Lv R, Yu L, Huang W (2010) Hydroxyethyl starch 130/0.4 inhibits production of plasma proinflammatory cytokines and attenuates nuclear factor-kappaB activation and toll-like receptors expression in monocytes during sepsis. J Surg Res 160:133–138. doi:10.1016/j.jss.2009.05.050
Yu M, Shao D, Liu J, Zhu J, Zhang Z, Xu J (2007) Effects of ketamine on levels of cytokines, NF-kappaB, and TLRs in rat intestine during CLP-induced sepsis. Int Immunopharmacol 7:1076–1082. doi:10.1016/j.intimp.2007.04.003
Gurjala AN, Geringer MR, Seth AK, Hong SJ, Smeltzer MS, Galiano RD, Leung KP, Mustoe TA (2011) Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen 19:400–410. doi:10.1111/j.1524-475X.2011.00690.x
Kumar A (2009) Perioperative management of anemia: limits of blood transfusion and alternatives to it. Cleve Clin J Med 76(Suppl 4):S112–S118. doi:10.3949/ccjm.76.s4.18
Webb ML, Cerrato F, Rosen H, Divasta AD, Greene AK, Labow BI (2011) The effect of obesity on early outcomes in adolescents undergoing reduction mammaplasty. Ann Plast Surg. doi:10.1097/SAP.0b013e3182145370
Setala L, Papp A, Joukainen S, Martikainen R, Berg L, Mustonen P, Harma M (2009) Obesity and complications in breast reduction surgery: are restrictions justified? J Plast Reconstr Aesthet Surg 62:195–199. doi:10.1016/j.bjps.2007.10.043
O’Grady KF, Thoma A, Dal Cin A (2005) A comparison of complication rates in large and small inferior pedicle reduction mammaplasty. Plast Reconstr Surg 115:736–742. doi:00006534-200503000-00009
Acknowledgments
The authors thank Peter Koerfgen for English proofreading. All costs were handled by the hospital and the authors themselves. No funding from third parties was received.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dieterich, M., Reimer, T., Kundt, G. et al. The Role of Hydroxyethyl Starch in Preventing Surgical-Site Infections and Nipple Necrosis in Patients Undergoing Reduction Mammaplasty: A Prospective Case–Control Study of 334 Patients. Aesth Plast Surg 37, 554–560 (2013). https://doi.org/10.1007/s00266-013-0113-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-013-0113-5